Ph.D., R&D Manager, DNAGenotek/Novosanis
Biography
Brice Le François currently leads the technology research teams at DNA Genotek (microbiome devices) and Diversigen (microbiome services) as a Senior R&D manager. He obtained his Ph.D. in Biochemistry from the University of Ottawa and has over 20 years of experience in research across a wide range of fields, including cancer and neuroscience. Since joining the R&D team at DNA Genotek, he has worked extensively on optimizing the stabilization and processing of human microbiome samples. His team spearheaded the development of novel tools and workflows for low biomass samples as well as novel DNA/RNA stabilization chemistries that enable multi-omics analyses of gut microbiome samples and beyond.
Talk
Health Monitoring Showcase:
DNAGenotek/Novosanis
Novosanis is a wholly owned subsidiary of OraSure Technologies Inc (NASDAQ: OSUR) and an innovative developer and producer of medical devices improving the quality of diagnostic tests for infectious diseases and oncology.
Design Of Self-Sampling First-Void Urine Collection Method
Different Colli-Pee® volume variants are explored, while maintaining sample quality and respecting urine-to-preservative ratio.
Session Abstract – PMWC 2023 Silicon Valley
Showcase Track S1 - January 26 11.00 A.M.-11.15 A.M.,Showcase Track S1 - January 27 10.15 A.M.-10.30 A.M.
The PMWC 2023 Health Monitoring Showcase will provide 15 minute speaking opportunities for selected companies working with the latest technologies in remote patient and care monitoring, providing devices that are smart and integrated with high-touch approaches, sensors, data collection and analytical capabilities translating patient vital signs into useful insights and alert triggers. These companies will share their innovative products to an audience of leading investors, potential clients, and partners. The PMWC 2019 Health Monitoring Showcase will exhibit the latest innovations that lead to products, systems, and services that empower patients with chronic conditions to better understand and self-manage their conditions and provide clinicians with easy, efficient monitoring that enhance patients’ lives and enable the delivery of better outcomes at lower cost.
